Arrhythmias & electrophysiology
Impact of an Organized Treatment Pathway on Management of Atrial Fibrillation: The ER2EP Study
Authors' conclusion
This study provides evidence that having an organized pathway from the emergency department for AF patients involving electrophysiology services can improve early access to definitive therapies and clinical outcomes.
Study context
- Population
- Patients with atrial fibrillation (AF) seen in the emergency room
- Participants
- 500 patients
- Exposure
- Organized AF treatment pathway vs routine care
- ER2EPn = 250
- Controln = 250reference
- Outcome
- Time to ablation, time to anticoagulation initiation, antiarrhythmic drug initiation
Methodological detailsmulticentre, multivariable regression
- Multicentre
- Multivariable regression
Main finding
As reported in the abstract
| Group | Time to ablation | Time to anticoagulation initiation | Antiarrhythmic drug initiation |
|---|---|---|---|
| ER2EP | 56 ± 50.9 days | 2.1 ± 1.6 days | 4.8 ± 7.1 days |
| Control | 183.3 ± 109.5 days | 19.7 ± 35 days | 24.7 ± 44.4 days |
Time to ablation
ER2EP56 ± 50.9 days
Control183.3 ± 109.5 days
Time to anticoagulation initiation
ER2EP2.1 ± 1.6 days
Control19.7 ± 35 days
Antiarrhythmic drug initiation
ER2EP4.8 ± 7.1 days
Control24.7 ± 44.4 days
- ER2EP vs Control: P < 0.001 — time to ablation
- ER2EP vs Control: P < 0.001 — time to anticoagulation initiation
- ER2EP vs Control: P < 0.001 — antiarrhythmic drug initiation
Observational data: associations, not effects.
Further findings
Length of stay
P = 0.002
Original publication
Impact of an Organized Treatment Pathway on Management of Atrial Fibrillation: The ER2EP Study. JACC Adv. Published 21 March 2024. doi:10. 1016/ j. jacadv. 2024. 100905
Composed by AI from the published abstract and checked against it. How Briefs are made →